Cecilia Sun

Cecilia Sun is a seasoned professional in business development and strategy within the life sciences sector, currently serving as Vice President of Business Development & Strategy at Stylus Medicine since July 2023. Prior experience includes a progressive leadership role at Entrada Therapeutics from 2018 to 2023, where Cecilia held multiple positions, culminating in Vice President. Additional experience encompasses a role in business development at Genentech focused on gRED Oncology, venture capital at Aisling Capital, and investment banking at Credit Suisse. Cecilia began a career in business development at Cephalon. Educational qualifications include an MBA in Healthcare Management from The Wharton School and dual bachelor’s degrees in Biology and Economics from the University of Pennsylvania, with a distinction in Biology and concentrations in Finance, Healthcare Management, and Policy from The Wharton School.